APYX Financial Overview

Comprehensive financial analysis and stock performance data for APYX. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

APYX

Apyx Medical Corporation

Healthcare
CEO: Charles D. Goodwin II
IPO: 2019-01-02
220 employees
$1.75
-0.16 (-9.14%)

Market Cap

66.14M

Enterprise Value

40M

Revenue (TTM)

48.1M

Net Income

-23,463,000

P/E Ratio

-3.10x

ROE

-158.68%

Valuation Metrics
Market Cap
66M
Enterprise Value
40M
P/E Ratio
-3.10x
P/S Ratio
1.40x
P/B Ratio
5.92x
EV/Sales
0.84x
EV/FCF
-3.04x
Earnings Yield
-32.21%
FCF Yield
-19.88%
Price to Operating Cash Flow
-5.01x
Gross Margin
51.59%
Margin Metrics
Operating Margin
-32.31%
Net Margin
-42.37%
Pretax Margin
-42.07%
ROIC
-30.32%
Dividends
Payout Ratio
0.00%
Dividend Yield
0.00%
Dividend per Share
$0.00
Return Metrics
ROE
-158.68%
ROCE
-30.17%
ROA
-33.31%
PEG Ratio
-0.21x
Payout Ratio
0.00%
Financial Health
Debt to Assets
7.96%
Net Debt/EBITDA
1.82x
Growth Metrics
3Y Revenue Growth
-1.43%
5Y Revenue Growth
10.37%
10Y Revenue Growth
-1.44%
3Y Net Income Growth
-20.16%
5Y Net Income Growth
-3.07%
10Y Net Income Growth
2.85%
3Y OCF Growth
-30.78%
5Y OCF Growth
1.24%
10Y OCF Growth
NaN%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

APYX
AugAugSepOctNovDecJanFebMarAprMayJunJulJul0.81.31.82.7
APYX·Total: 52.17%·CAGR: 52.17%
Apyx Medical Corporation | Financial Overview | Monexa